Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan

Background. All-oral combination of direct-acting antivirals could lead to higher sustained virologic response (SVR) in hepatitis C virus (HCV)-infected patients. In the present study, we examined the efficacy and safety of the dual oral treatment with HCV nonstructural protein (NS) 5A inhibitor dac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Yasui, Shin, Nakamura, Masato, Suzuki, Eiichiro, Arai, Makoto, Haga, Yuki, Sasaki, Reina, Wu, Shuang, Nakamoto, Shingo, Imazeki, Fumio, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893555/
https://www.ncbi.nlm.nih.gov/pubmed/27279790
http://dx.doi.org/10.7150/ijms.15519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893555/
https://www.ncbi.nlm.nih.gov/pubmed/27279790
http://dx.doi.org/10.7150/ijms.15519

Ejemplares similares